A More Atherogenic Serum Lipoprotein Profile Is Present in Women with Polycystic Ovary Syndrome: A Case-Control Study | Zendy

Olivier Valkenburg | Zendy; Régine P.M. SteegersTheunissen | Zendy; H.P.M. Smedts | Zendy; Geesje M. DallingaThie | Zendy; Bart C.J.M. Fauser | Zendy; Egbertine H. Westerveld | Zendy; Joop S.E. Laven | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A More Atherogenic Serum Lipoprotein Profile Is Present in Women with Polycystic Ovary Syndrome: A Case-Control Study

Author(s) -

Olivier Valkenburg,

Régine P.M. SteegersTheunissen,

H.P.M. Smedts,

Geesje M. DallingaThie,

Bart C.J.M. Fauser,

Egbertine H. Westerveld,

Joop S.E. Laven

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2007-1756

Subject(s) - polycystic ovary , hyperandrogenism , medicine , endocrinology , free androgen index , body mass index , apolipoprotein b , lipid profile , sex hormone binding globulin , insulin resistance , cholesterol , insulin , androgen , hormone

Polycystic ovary syndrome (PCOS) is associated with a higher frequency of cardiovascular risk factors. Apolipoprotein (apo) A-I and apoB are potent markers for cardiovascular risk. Data on apo levels in women with PCOS are scarce and contradictory.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research